News and Announcements
OncoSil (ASX: OSL) Accelerates Operational Progress with 10 Major Cancer Treatment Centres & Reports $8.0m Cash Balance
- Published August 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
OncoSil Medical Ltd (ASX:OSL), a medical device company which focuses on localised treatments for patients with pancreatic and liver cancer, has released its Appendix 4C – Quarterly Cashflow report for the quarter ended 30 June 2017.
KEY TAKEAWAYS:
- Accelerated operational progress, with 10 major cancer treatment centres now activated
- 13 patients now enrolled into current study (up from 1 patient at the end of FY3Q 17)
- 4 patients in study group implanted with OncoSil™ device on 21 July
- 1 Compassionate access patient implanted with OncoSil™ device on 21 July
- Cash balance as at 30 June of $8.0m, with cash outflow from operations for the quarter of $2.4m
OncoSil Chief Executive Officer, Daniel Kenny commented:
“Our team’s primary focus during the past quarter has been to continue driving patient recruitment to our activated sites which are part of our global study programme – with additional sites now on board, including leading sites in both the UK and US, we look forward to reaching our goal of 20 patients over the coming weeks, and providing the required supplemental data to BSI for CE Mark approval.
While I am encouraged by our current rate of recruitment and the growing list of globally prestigious cancer centres involved in our clinical programme, recruitment for this study is challenging.
The Company will need to accelerate operational performance in the coming weeks if it is to secure CE Mark in 2017. However, given the significant advances in 2017, and particularly in this past quarter, Oncosil’s Board is confident that we are proceeding in the right manner and should near full patient recruitment in the coming weeks.”
Company Updates
Everything is now competing for the same dollar
Key takeaways As recently as 2022, Germany and Japan could borrow for 30 years at close to zero. That world is gone, and AI is now bidding for what is left. Over the past fortnight, I listened to founders, operators and allocators describe where their industries are heading. They covered four very different frontiers. Each […]
Australia has not held 90 days of fuel since 2012. The fix may start at a sewage plant.
A decommissioned council treatment site in Bundaberg is being built into a $188.9 million biorefinery. Its managing director is candid that the largest revenue line is not yet contracted. Australia has not met its international 90-day fuel reserve obligation since 2012. Around 90 per cent of the country’s liquid fuel is imported. Andy Whitmore, Managing […]
Forget Startups: Why Magnetic Alliance is Betting on “Boring” Mid-Market Turnarounds
While Australia’s venture capital scene spent years chasing unprofitable tech startups and speculative high-growth plays, Mark Lim was quietly taking a radically different path. The Managing Partner of Magnetic Alliance Capital sees the nation’s richest investment opportunities hiding in plain sight: inside thousands of unglamorous, profitable, but operationally sluggish mid-market businesses. Speaking on Wholesale Investor’s […]
Backed By Leading Investment Groups and Family Offices
